-
1
-
-
79952224794
-
People's Republic of China wrestles with lung cancer
-
Wen C, Dehnel T. People's Republic of China wrestles with lung cancer. Lancet Oncol. 2011;12(1):15.
-
(2011)
Lancet Oncol
, vol.12
, Issue.1
, pp. 15
-
-
Wen, C.1
Dehnel, T.2
-
2
-
-
27544479318
-
Role of tyrosine kinase inhibitors in cancer therapy
-
Arora A, Scholar EM. Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther. 2005;315(3):971-979.
-
(2005)
J Pharmacol Exp Ther
, vol.315
, Issue.3
, pp. 971-979
-
-
Arora, A.1
Scholar, E.M.2
-
3
-
-
17844390172
-
Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: Current knowledge and future directions
-
Pao W, Miller VA. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol. 2005;23(11):2556-2568.
-
(2005)
J Clin Oncol
, vol.23
, Issue.11
, pp. 2556-2568
-
-
Pao, W.1
Miller, V.A.2
-
4
-
-
1842791537
-
Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation
-
Thomas SM, Grandis JR. Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Cancer Treat Rev. 2004;30(3):255-268.
-
(2004)
Cancer Treat Rev
, vol.30
, Issue.3
, pp. 255-268
-
-
Thomas, S.M.1
Grandis, J.R.2
-
5
-
-
33847246805
-
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
-
Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166-180.
-
(2007)
Neoplasia
, vol.9
, Issue.2
, pp. 166-180
-
-
Rhodes, D.R.1
Kalyana-Sundaram, S.2
Mahavisno, V.3
-
6
-
-
0036718369
-
Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling
-
Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res. 2002;8(9):2912-2923.
-
(2002)
Clin Cancer Res
, vol.8
, Issue.9
, pp. 2912-2923
-
-
Tuxhorn, J.A.1
Ayala, G.E.2
Smith, M.J.3
Smith, V.C.4
Dang, T.D.5
Rowley, D.R.6
-
7
-
-
33847701326
-
Expression and mutation analysis of the discoidin domain receptors 1 and 2in non-small cell lung carcinoma
-
Ford CE, Lau SK, Zhu CQ, Andersson T, Tsao MS, Vogel WF. Expression and mutation analysis of the discoidin domain receptors 1 and 2in non-small cell lung carcinoma. Br J Cancer. 2007;96(5):808-814.
-
(2007)
Br J Cancer
, vol.96
, Issue.5
, pp. 808-814
-
-
Ford, C.E.1
Lau, S.K.2
Zhu, C.Q.3
Andersson, T.4
Tsao, M.S.5
Vogel, W.F.6
-
8
-
-
77954357667
-
Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas
-
Yang SH, Baek HA, Lee HJ, et al. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncol Rep. 2010;24(2):311-319.
-
(2010)
Oncol Rep
, vol.24
, Issue.2
, pp. 311-319
-
-
Yang, S.H.1
Baek, H.A.2
Lee, H.J.3
-
9
-
-
80052341805
-
Detection of Brk expression in non-small cell lung cancer: Clinicopathological relevance
-
Fan C, Zhao Y, Liu D, Zhang X, Wang E. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance. Tumour Biol. 2011;32(5):873-880.
-
(2011)
Tumour Biol
, vol.32
, Issue.5
, pp. 873-880
-
-
Fan, C.1
Zhao, Y.2
Liu, D.3
Zhang, X.4
Wang, E.5
-
10
-
-
0028237509
-
Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours
-
Mitchell PJ, Barker KT, Martindale JE, et al. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene. 1994;9(8):2383-2390.
-
(1994)
Oncogene
, vol.9
, Issue.8
, pp. 2383-2390
-
-
Mitchell, P.J.1
Barker, K.T.2
Martindale, J.E.3
-
11
-
-
0027385426
-
A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes
-
Lee ST, Strunk KM, Spritz RA. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene. 1993;8(12):3403-3410.
-
(1993)
Oncogene
, vol.8
, Issue.12
, pp. 3403-3410
-
-
Lee, S.T.1
Strunk, K.M.2
Spritz, R.A.3
-
12
-
-
0030827253
-
BRK tyrosine kinase expression in a high proportion of human breast carcinomas
-
Barker KT, Jackson LE, Crompton MR. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene. 1997;15(7):799-805.
-
(1997)
Oncogene
, vol.15
, Issue.7
, pp. 799-805
-
-
Barker, K.T.1
Jackson, L.E.2
Crompton, M.R.3
-
13
-
-
0032789582
-
BRK/Sik expression in the gastrointestinal tract and in colon tumors
-
Llor X, Serfas MS, Bie W, et al. BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin Cancer Res. 1999;5(7):1767-1777.
-
(1999)
Clin Cancer Res
, vol.5
, Issue.7
, pp. 1767-1777
-
-
Llor, X.1
Serfas, M.S.2
Bie, W.3
-
14
-
-
1542358939
-
The Brk protein tyrosine kinase as a therapeutic target in cancer: Opportunities and challenges
-
Harvey AJ, Crompton MR. The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges. Anticancer Drugs. 2004;15(2):107-111.
-
(2004)
Anticancer Drugs
, vol.15
, Issue.2
, pp. 107-111
-
-
Harvey, A.J.1
Crompton, M.R.2
-
15
-
-
0042786007
-
Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation
-
Harvey AJ, Crompton MR. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene. 2003;22(32):5006-5010.
-
(2003)
Oncogene
, vol.22
, Issue.32
, pp. 5006-5010
-
-
Harvey, A.J.1
Crompton, M.R.2
-
16
-
-
50549095021
-
Brk is coamplified with ErbB2 to promote proliferation in breast cancer
-
Xiang B, Chatti K, Qiu H, et al. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc Natl Acad Sci U S A. 2008;105(34):12463-12468.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.34
, pp. 12463-12468
-
-
Xiang, B.1
Chatti, K.2
Qiu, H.3
-
17
-
-
0034676337
-
Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation
-
Kamalati T, Jolin HE, Fry MJ, Crompton MR. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene. 2000;19(48):5471-5476.
-
(2000)
Oncogene
, vol.19
, Issue.48
, pp. 5471-5476
-
-
Kamalati, T.1
Jolin, H.E.2
Fry, M.J.3
Crompton, M.R.4
-
18
-
-
53049087852
-
Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
-
Aubele M, Walch AK, Ludyga N, et al. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br J Cancer. 2008;99(7):1089-1095.
-
(2008)
Br J Cancer
, vol.99
, Issue.7
, pp. 1089-1095
-
-
Aubele, M.1
Walch, A.K.2
Ludyga, N.3
-
19
-
-
10044284340
-
Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin
-
Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol. 2004;24(24):10558-10572.
-
(2004)
Mol Cell Biol
, vol.24
, Issue.24
, pp. 10558-10572
-
-
Chen, H.Y.1
Shen, C.H.2
Tsai, Y.T.3
Lin, F.C.4
Huang, Y.P.5
Chen, R.H.6
-
20
-
-
65549108638
-
STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation
-
Ikeda O, Miyasaka Y, Sekine Y, et al. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation. Biochem Biophys Res Commun. 2009;384(1):71-75.
-
(2009)
Biochem Biophys Res Commun
, vol.384
, Issue.1
, pp. 71-75
-
-
Ikeda, O.1
Miyasaka, Y.2
Sekine, Y.3
-
21
-
-
24644462342
-
Interaction between Brk kinase and insulin receptor substrate-4
-
Qiu H, Zappacosta F, Su W, Annan RS, Miller WT. Interaction between Brk kinase and insulin receptor substrate-4. Oncogene. 2005;24(36):5656-5664.
-
(2005)
Oncogene
, vol.24
, Issue.36
, pp. 5656-5664
-
-
Qiu, H.1
Zappacosta, F.2
Su, W.3
Annan, R.S.4
Miller, W.T.5
-
22
-
-
80052584394
-
Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors
-
Zeng H, Belanger DB, Curran PJ, et al. Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors. Bioorg Med Chem Lett. 2011;21(19):5870-5875.
-
(2011)
Bioorg Med Chem Lett
, vol.21
, Issue.19
, pp. 5870-5875
-
-
Zeng, H.1
Belanger, D.B.2
Curran, P.J.3
-
23
-
-
18544365698
-
Gene-expression profiles predict survival of patients with lung adenocarcinoma
-
Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002;8(8):816-824.
-
(2002)
Nat Med
, vol.8
, Issue.8
, pp. 816-824
-
-
Beer, D.G.1
Kardia, S.L.2
Huang, C.C.3
-
24
-
-
0037447191
-
Transcriptional gene expression profiling of small cell lung cancer cells
-
Pedersen N, Mortensen S, Sørensen SB, et al. Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res. 2003;63(8):1943-1953.
-
(2003)
Cancer Res
, vol.63
, Issue.8
, pp. 1943-1953
-
-
Pedersen, N.1
Mortensen, S.2
Sørensen, S.B.3
-
25
-
-
0035923583
-
Diversity of gene expression in adenocarcinoma of the lung
-
Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 2001;98(24):13784-13789.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, Issue.24
, pp. 13784-13789
-
-
Garber, M.E.1
Troyanskaya, O.G.2
Schluens, K.3
-
26
-
-
77956418156
-
Gene expression-based classification of non-small cell lung carcinomas and survival prediction
-
Hou J, Aerts J, den Hamer B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 2010;5(4):e10312.
-
(2010)
PLoS One
, vol.5
, Issue.4
-
-
Hou, J.1
Aerts, J.2
den Hamer, B.3
-
27
-
-
45749140422
-
Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival
-
Landi MT, Dracheva T, Rotunno M, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One. 2008;3(2):e1651.
-
(2008)
PLoS One
, vol.3
, Issue.2
-
-
Landi, M.T.1
Dracheva, T.2
Rotunno, M.3
-
28
-
-
28244499333
-
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model
-
Stearman RS, Dwyer-Nield L, Zerbe L, et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol. 2005;167(6):1763-1775.
-
(2005)
Am J Pathol
, vol.167
, Issue.6
, pp. 1763-1775
-
-
Stearman, R.S.1
Dwyer-Nield, L.2
Zerbe, L.3
-
29
-
-
34347209095
-
Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme
-
Su LJ, Chang CW, Wu YC, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics. 2007;8:140.
-
(2007)
BMC Genomics
, vol.8
, pp. 140
-
-
Su, L.J.1
Chang, C.W.2
Wu, Y.C.3
-
30
-
-
28444448000
-
Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues
-
Wachi S, Yoneda K, Wu R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics. 2005;21(23):4205-4208.
-
(2005)
Bioinformatics
, vol.21
, Issue.23
, pp. 4205-4208
-
-
Wachi, S.1
Yoneda, K.2
Wu, R.3
-
31
-
-
10744226708
-
A training-testing approach to the molecular classification of resected non-small cell lung cancer
-
Yamagata N, Shyr Y, Yanagisawa K, et al. A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res. 2003;9(13):4695-4704.
-
(2003)
Clin Cancer Res
, vol.9
, Issue.13
, pp. 4695-4704
-
-
Yamagata, N.1
Shyr, Y.2
Yanagisawa, K.3
|